Bernstein Downgrades Gilead Sciences (GILD) to Market Perform
GILD Hot Sheet
Rating Summary:12 Buy, 7 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 16 | Down: 7 | New: 22
Bernstein downgrades Gilead Sciences (Nasdaq: GILD) from Outperform to Market Perform.
To see all the upgrades/downgrades on shares of GILD, visit our Analyst Ratings page.
Gilead Sciences, Inc. (Gilead) is a biopharmaceutical company that discovers, develops and commercializes therapeutics.
To see all the upgrades/downgrades on shares of GILD, visit our Analyst Ratings page.
Gilead Sciences, Inc. (Gilead) is a biopharmaceutical company that discovers, develops and commercializes therapeutics.
You May Also Be Interested In
- UPDATE: UBS Downgrades Wisconsin Energy (WEC) to Neutral; Taking Some Off The Table
- Brean Murray Carret & Co. Downgrades NetApp (NTAP) to Hold; Visibility Challenged
- JPMorgan Downgrades Heinz (HNZ) to Neutral
Create E-mail Alert Related Categories
DowngradesSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
